covid 19 News and Research

RSS

Researchers develop eleven SARS-CoV-2 RBD nanobodies using computational design

To develop therapeutics that block this binding process, a team of researchers recently used an integrated computational approach to design nanobodies (Nbs) against the SARS-CoV-2 RBD, using neutralizing/monoclonal antibodies specific to RBD of the spike protein.

27 Apr 2021

Big investors push nursing homes to upgrade care and working conditions

Nursing homes and long-term care facilities, where 182,000 Americans perished during the covid pandemic, have taken heat from government regulators, residents and their families. Now the industry is hearing it from an unexpected source: their investors.

27 Apr 2021

Pandemic imperiled non-English speakers more than others

In March 2020, just weeks into the Covid-19 pandemic, the incident command center at Brigham and Women’s Hospital in Boston was scrambling to understand this deadly new disease. It appeared to be killing more Black and brown patients than whites. For Latinos, there was an additional warning sign: language.

27 Apr 2021

World Immunization Week: Vaccination in 2021

News-Medical talks to experts in different areas of the medical sector on why immunization week is so prevalent in 2021.

27 Apr 2021

Study in Ireland identifies underlying conditions associated with severe COVID-19 outcomes

A national study of 20,000 patients conducted by RCSI University of Medicine and Health Sciences and the HSE Health Protection Surveillance Centre (HPSC) has identified the underlying conditions that are associated with more severe outcomes from COVID-19 in an Irish setting.

27 Apr 2021

Menopausal symptoms in breast cancer patients could be reduced through CBT delivered by nurses

Menopausal symptoms - hot flushes and night sweats – experienced by women with breast cancer can be reduced through group cognitive behavioral therapy (CBT) delivered by breast care nurses, a new clinical trial reveals.

27 Apr 2021

New study looks at the impact of Covid-19 pandemic on UK healthcare

Just one third of people in the UK managed to access the hospital care they needed at the peak of the first wave of the Covid-19 pandemic – according to new research from the University of East Anglia.

27 Apr 2021

Corticosteroids not recommended to treat smell loss due to Covid-19, study shows

Steroids should not be used to treat smell loss caused by Covid-19 according to an international group of smell experts, including Prof Carl Philpott from the University of East Anglia.

27 Apr 2021

Shift workers more likely to test positive for Covid-19 in hospital

People who work shifts appear to be significantly more likely to end up in hospital with Covid-19 than people who have regular work patterns, suggests research published online in the journal Thorax.

27 Apr 2021

Physician-scientist Dr. David Lyden elected into Association of American Physicians

Weill Cornell Medicine physician-scientist Dr. David Lyden, whose research has led to groundbreaking discoveries about how cancer spreads, has been elected into the esteemed Association of American Physicians.

27 Apr 2021

University-industry partnership leads to a new rapid COVID-19 test

A partnership between UC Davis and Maurice J. Gallagher, Jr., chairman and CEO of Allegiant Travel Company, has led to a new rapid COVID-19 test.

27 Apr 2021

Triple mutation in SARS-CoV-2 seen in second wave of COVID-19 in India

Researchers sequenced the viral genome from samples in the state of Maharashtra and found a unique combination of three mutations that suggest the SARS-CoV-2 virus is continually evolving to evade the human immune response.

27 Apr 2021

Most faculty members deal with student mental health issues, but only a few have received training

Nearly 80 percent of higher education faculty report dealing with student mental health issues--issues that more than 90 percent of faculty believe have worsened or significantly worsened during the pandemic, according to a new nationwide survey led by a Boston University mental health researcher.

27 Apr 2021

Doctoral students recommend changing the protocols around use of tear gas on crowds

A new study by five doctoral students in neuroscience at the University of Minnesota Medical School calls attention to a lack of regulation and unknown long-term health effects of tear gas. Based on their research, the group recommends changing the protocols around the use of tear gas as a crowd control measure at both the local and national level.

27 Apr 2021

Nanobodies neutralize SARS-CoV-2 in pre-clinical model

A team of Australian researchers at the Walter and Eliza Hall Institute of Medical Research (WEHI), the Doherty Institute, and the Kirby Institute have identified neutralizing nanobody cocktails that block the SARS-CoV-2 virus from entering cells in pre-clinical models.

27 Apr 2021

Research suggests that Ginkgo biloba extract contains naturally occurring inhibitors against SARS-CoV-2

Researchers at Shihezi University in China found that Gingko Biloba leaves extract contains the most potent SARS-CoV-2 3-Chymotrypsin-like protease (3CLpro). This virally encoded main proteinase is essential for viral replication in coronaviruses.

27 Apr 2021

Study reveals a hidden role of circulating microRNA as a driver of SARS-CoV-2 infection

In a methodological tour-de-force study, a large group of researchers from the USA and the United Kingdom analyzed patient transcriptomic data in-depth and discovered a circulating microRNA (miR-2392) that is directly implicated in the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) machinery during the infection process.

26 Apr 2021

Study finds no evidence to support link between ABO blood group and COVID-19 risk

Researchers from the Boston University School of Public Health in the United States say there is no evidence to support a correlation between ABO blood group and the risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or the severity of coronavirus disease 2019 (COVID-19).

26 Apr 2021

Prior SARS-CoV-2 infection and Pfizer-BioNTech’s COVID-19 vaccine provide similar immunity

Researchers in Israel have conducted a study showing that the immunity provided against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease (COVID-19) – is similar following natural infection or immunization with the Pfizer-BioNTech BNT162b2 vaccine.

26 Apr 2021

Stroke-related deaths increased during the first lockdown

Deaths of people who suffered strokes increased during the first lockdown compared to the three previous years, new data analysis has found. Despite the pandemic, health care quality was maintained at a high level.

26 Apr 2021

covid 19 News and Research

Researchers develop eleven SARS-CoV-2 RBD nanobodies using computational design

Big investors push nursing homes to upgrade care and working conditions

Pandemic imperiled non-English speakers more than others

World Immunization Week: Vaccination in 2021

Study in Ireland identifies underlying conditions associated with severe COVID-19 outcomes

Menopausal symptoms in breast cancer patients could be reduced through CBT delivered by nurses

New study looks at the impact of Covid-19 pandemic on UK healthcare

Corticosteroids not recommended to treat smell loss due to Covid-19, study shows

Shift workers more likely to test positive for Covid-19 in hospital

Physician-scientist Dr. David Lyden elected into Association of American Physicians

University-industry partnership leads to a new rapid COVID-19 test

Triple mutation in SARS-CoV-2 seen in second wave of COVID-19 in India

Most faculty members deal with student mental health issues, but only a few have received training

Doctoral students recommend changing the protocols around use of tear gas on crowds

Nanobodies neutralize SARS-CoV-2 in pre-clinical model

Research suggests that Ginkgo biloba extract contains naturally occurring inhibitors against SARS-CoV-2

Study reveals a hidden role of circulating microRNA as a driver of SARS-CoV-2 infection

Study finds no evidence to support link between ABO blood group and COVID-19 risk

Prior SARS-CoV-2 infection and Pfizer-BioNTech’s COVID-19 vaccine provide similar immunity

Stroke-related deaths increased during the first lockdown

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News